AXSOME THERAPEUTICS, INC. (AXSM) Total liabilities 2022–2025
AXSOME THERAPEUTICS, INC. (AXSM) total liabilities at each fiscal year-end, per SEC filings.
$601.5MFY2025 · since FY2022: $221.9M → $601.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $601.5M | +17.6% |
| FY2024 | $511.5M | +28.8% |
| FY2023 | $397.3M | +79.0% |
| FY2022 | $221.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More AXSM financial trends
AXSM RevenueAXSM Net incomeAXSM Net marginAXSM Gross profitAXSM Gross marginAXSM Operating incomeAXSM Operating marginAXSM Operating cash flowAXSM Free cash flowAXSM Capital expendituresAXSM Return on equityAXSM Stock buybacksAXSM Dividends paidAXSM Total assetsAXSM Shareholders’ equityAXSM overview →